Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:approves |
December 2020
|
| gptkbp:brand |
gptkb:Comirnaty
|
| gptkbp:clinical_trial |
tens of thousands
Phase 3 trials |
| gptkbp:clinical_use |
COVID-19 prevention
|
| gptkbp:community_health |
reduced hospitalization rates
reduced transmission rates |
| gptkbp:developed_by |
gptkb:Pfizer
gptkb:Bio_NTech |
| gptkbp:distribution |
widely distributed
|
| gptkbp:dosage_form |
recommended after initial series
two doses |
| gptkbp:effective_date |
Emergency Use Authorization
|
| gptkbp:first_dose_interval |
21 days
|
| gptkbp:funding |
government and private sectors
|
| https://www.w3.org/2000/01/rdf-schema#label |
BNT162b2
|
| gptkbp:is_effective_against |
approximately 95%
|
| gptkbp:is_vulnerable_to |
available in many countries
collaborative international efforts global vaccination efforts preventive vaccine against variants continuously evaluated nationwide campaigns critical in pandemic response ongoing for new variants provided to healthcare professionals based on clinical trial data addressed by public campaigns assessed against new variants focused on long-term immunity monitored in real-world studies requires ultra-cold freezers significantly reduced severe cases updated based on emerging data coordinated by governments and NGOs |
| gptkbp:market |
conducted by health authorities
|
| gptkbp:marketed_as |
gptkb:Pfizer/_Bio_NTech
|
| gptkbp:mechanism_of_action |
induces immune response
|
| gptkbp:regulatory_compliance |
gptkb:FDA
gptkb:WHO gptkb:EMA |
| gptkbp:route_of_administration |
intramuscular injection
|
| gptkbp:safety_measures |
ongoing studies
|
| gptkbp:side_effect |
fatigue
headache muscle pain fever chills |
| gptkbp:storage |
-70° C to -80° C
|
| gptkbp:supply_chain |
cold chain logistics
|
| gptkbp:target_audience |
adults
children 12 years and older |
| gptkbp:targets |
gptkb:COVID-19
|
| gptkbp:type |
gptkb:vaccine
|
| gptkbp:vaccine_information |
available on health websites
|
| gptkbp:vaccine_syringe |
specialized syringes used
|
| gptkbp:vaccine_updates |
regularly published by health organizations
|
| gptkbp:bfsParent |
gptkb:Pfizer
gptkb:Pfizer_Inc. |
| gptkbp:bfsLayer |
4
|